Vimarsana
Biggest News Aggregation in the World

Adaptive Immunity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adaptive Immunity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adaptive Immunity Today - Breaking & Trending Today

Dr. Christian Brander and Dr. Mala Maini Join World-class Scientific Advisory Board of AstriVax - Vimarsana News

Dr. Christian Brander and Dr. Mala Maini Join World-class Scientific Advisory Board of AstriVax

Christian Brander, Ph.D., is a leading expert on T cell responses to viral infections and brings an important blend of academic and biotech experience.Mala Maini, MD, Ph.D., is a professor of viral immunology at University College London with key expertise in adaptive immunity to hepatitis B, liver cancer, and SARS-CoV-2. Together with the other distinguished vaccine development experts on the company’s scientific advisory board, they will support AstriVax in advancing its innovative plug-and-pl

Source: yahoo.com
Beyond Greens Review 2023: Does The Powder Boost Energy? - Vimarsana News

Beyond Greens Review 2023: Does The Powder Boost Energy?

Beyond Greens is a powerful and efficient weight loss supplement 2023. Read our Beyond Greens review to know more about this product.

6 Home Remedies for a Cold & Cough During Pregnancy 2022 - Vimarsana News

6 Home Remedies for a Cold & Cough During Pregnancy 2022

You may encounter a cold or cough while pregnant due to some reasons. Read on to find out home remedies for cough during pregnancy 2023.

Oral Presentation of Interim Data from the AURELIO-03 Study of SOT101 at the 2022 ASCO Annual Meetin - Vimarsana News

Oral Presentation of Interim Data from the AURELIO-03 Study of SOT101 at the 2022 ASCO Annual Meetin

SOTIO will share interim safety and efficacy results from SOTIO’s AURELIO-03 study on Saturday, June 4AURELIO-03 is a Phase 1/1b dose escalation study of the interleukin-15 superagonist SOT101 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumorsBASEL, Switzerland, April 27, 202...

I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting - Vimarsana News

I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI and GAITHERSBURG, Md., March 9, 2022 /PRNewswire/ -- I-Mab (the 'Company') (Nasdaq: IMAB), a clinical-stage biopharmaceutical company com...